Related Experiment Video
Updated: Aug 10, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
The neural substrates of affective processing in depressed patients treated with venlafaxine
Richard J Davidson1, William Irwin, Michael J Anderle
1Department of Psychology, University of Wisconsin, 1202 West Johnson St., Madison, WI 53706, USA. rjdavids@facstaff.wisc.edu
Objective:
The purpose of this study was to use functional magnetic resonance imaging (fMRI) to probe the neural circuitry associated with reactivity to negative and positive affective stimuli in patients with major depressive disorder before treatment and after 2 and 8 weeks of treatment with venlafaxine. Relations between baseline neural activation and response to treatment were also evaluated.
Method:
Patients with major depressive disorder (N=12) and healthy comparison subjects (N=5) were scanned on three occasions, during which trials of alternating blocks of affective and neutral pictorial visual stimuli were presented. Symptoms were evaluated at each testing occasion, and both groups completed self-report measures of mood. Statistical parametric mapping was used to examine the fMRI data with a focus on the group-by-time interactions.
Results:
Patients showed a significant reduction in depressive symptoms with treatment. Group-by-time interactions in response to the negative versus neutral stimuli were found in the left insular cortex and the left anterior cingulate. At baseline, both groups showed bilateral activation in the visual cortices, lateral prefrontal cortex, and amygdala in response to the negative versus neutral stimuli, with patients showing greater activation in the visual cortex and less activation in the left lateral prefrontal cortex. Patients with greater relative anterior cingulate activation at baseline in response to the negative versus neutral stimuli showed the most robust treatment response.
Conclusions:
The findings underscore the importance of the neural circuitry activated by negative affect in depression and indicate that components of this circuitry can be changed within 2 weeks of treatment with antidepressant medication.
Insights
Functional magnetic resonance imaging (fMRI) revealed that major depressive disorder patients showed altered neural responses to negative stimuli. Treatment with venlafaxine modulated this neural circuitry, with baseline anterior cingulate activation predicting treatment response.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Major depressive disorder (MDD) is characterized by altered emotional processing.
- Understanding the neural basis of MDD treatment response is crucial for therapeutic development.
Purpose of the Study:
- To investigate neural circuitry reactivity to affective stimuli in MDD patients using fMRI.
- To examine how venlafaxine treatment affects this neural circuitry over 8 weeks.
- To correlate baseline neural activation with treatment outcomes.
Main Methods:
- fMRI scans were conducted on 12 MDD patients and 5 healthy controls at baseline, and after 2 and 8 weeks of venlafaxine treatment.
- Participants viewed alternating blocks of affective and neutral pictorial stimuli.
- Statistical parametric mapping analyzed fMRI data, focusing on group-by-time interactions.
Main Results:
- MDD patients exhibited significant symptom reduction with venlafaxine treatment.
- Group-by-time interactions in response to negative stimuli were observed in the left insular cortex and left anterior cingulate.
- Baseline anterior cingulate activation in response to negative stimuli predicted a more robust treatment response.
Conclusions:
- Neural circuitry activated by negative affect is critical in depression.
- Antidepressant medication, such as venlafaxine, can alter this neural circuitry within 2 weeks.
- These findings highlight potential neurobiological markers for treatment response in MDD.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
06:27An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression
Published on: July 11, 2025
Related Concept Videos
Depression: Overview
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...